 |

 |
Endemic
in China, Japan, Korea, and eastern areas of Russia |
 |
Outbreaks
now occur in previously nonendemic countries including
islands in the Torres Strait and northern Australia1,2 |
 |
Can
lead to death in 30% of cases and neuropsychiatric
sequelae in 50% of survivors3 |
Increased travel, increased exposure
 |
Since
the late 1980s, tourism to Asia has increased 64%4 |
 |
Japanese
encephalitis is the leading cause of viral encephalitis
in Asia and is a considerable public health problem,
with at least 50,000 cases per year1 |
 |
Risk
for travelers to rural areas can reach 1 per 5000
during a
1-month period5 |
|

 |
 |
| |
CDC recommends
vaccination for5:
 |
Persons
spending 30 days in endemic or epidemic
areas (especially rural) during transmission
season |
 |
Persons
spending <30 days in endemic areas
during epidemics or if performing extensive
outdoor activities in rural areas |
|
|
|
 |
|
References: 1. World Health Organization Position
Paper. Japanese encephalitis. Available at: http://www.who.int/vaccines-diseases/diseases/je.shtml.
Accessed December 10, 2001. 2. National Health and
Medical Research Council. Japanese encephalitis vaccine
added to immunisation schedule. Available at: http://www.health.gov.au/nhmrc/media/98releas/japan.htm.
Accessed December 7, 2001. 3. Centers for Disease
Control and Prevention (CDC). Health Information for
International Travel 2001-2002. Atlanta, Ga: US Dept
of Health and Human Services; 2001:74-80. 4. Tourism
Industries, International Trade Administration. U.S. resident
travel to Canada, Mexico and overseas countries historical
visitationoutbound 1987-1997 (one or more nights).
Available at: http://www.tinet.ita.doc.gov/view/f-1997-11-001/index.html.
Accessed December 14, 2001. 5. CDC. Inactivated Japanese
encephalitis virus vaccine: recommendations of the Advisory
Committee on Immunization Practices (AClP). MMWR Morb
Mortal Wkly Rep. 1993;42(RR-01):1-11. |
|
|